Drug Profile
CT 1578
Alternative Names: CT-1578; ONX-0805; SB-1578Latest Information Update: 28 Jun 2023
Price :
$50
*
At a glance
- Originator S*BIO
- Developer CTI BioPharma
- Class Antirheumatics; Small molecules
- Mechanism of Action Fms-like tyrosine kinase 3 inhibitors; Janus kinase-2 inhibitors; Macrophage colony stimulating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Rheumatoid arthritis